69 related articles for article (PubMed ID: 2531188)
41. The hsp70 gene CCAAT-binding factor mediates transcriptional activation by the adenovirus E1a protein.
Lum LS; Hsu S; Vaewhongs M; Wu B
Mol Cell Biol; 1992 Jun; 12(6):2599-605. PubMed ID: 1534142
[TBL] [Abstract][Full Text] [Related]
42. Nuclear factors bind to regulatory regions of the mouse kappa immunoglobulin gene.
Hromas R; Van Ness B
Nucleic Acids Res; 1986 Jun; 14(12):4837-48. PubMed ID: 3088544
[TBL] [Abstract][Full Text] [Related]
43. NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box.
Bielinska A; Krasnow S; Nabel GJ
J Virol; 1989 Sep; 63(9):4097-100. PubMed ID: 2527315
[TBL] [Abstract][Full Text] [Related]
44. Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.
Yu DH; Scorsone K; Hung MC
Mol Cell Biol; 1991 Mar; 11(3):1745-50. PubMed ID: 1671710
[TBL] [Abstract][Full Text] [Related]
45. A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer.
Scheuermann RH; Chen U
Genes Dev; 1989 Aug; 3(8):1255-66. PubMed ID: 2792763
[TBL] [Abstract][Full Text] [Related]
46. Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription.
Atchison ML; Perry RP
EMBO J; 1988 Dec; 7(13):4213-20. PubMed ID: 2854057
[TBL] [Abstract][Full Text] [Related]
47. The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A.
Ruppert JM; Vogelstein B; Kinzler KW
Mol Cell Biol; 1991 Mar; 11(3):1724-8. PubMed ID: 1825351
[TBL] [Abstract][Full Text] [Related]
48. Unknown Effects of Breast Enhancer Products on Diagnostic Imaging Outcomes.
Pacifici S; De La Camara Egea MA; Ibarra AS
J Breast Health; 2016 Jan; 12(1):50-51. PubMed ID: 28331732
[No Abstract] [Full Text] [Related]
49. Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Morales-Molina Á; Gambera S; Cejalvo T; Moreno R; Rodríguez-Milla MÁ; Perisé-Barrios AJ; García-Castro J
Cancer Immunol Immunother; 2018 Oct; 67(10):1589-1602. PubMed ID: 30066102
[TBL] [Abstract][Full Text] [Related]
50. NF-κB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector.
Machitani M; Sakurai F; Wakabayashi K; Nakatani K; Shimizu K; Tachibana M; Mizuguchi H
Sci Rep; 2016 Jan; 6():19922. PubMed ID: 26814140
[TBL] [Abstract][Full Text] [Related]
51. Inducible nitric oxide synthase expression inhibition by adenovirus E1A.
Cao W; Bao C; Lowenstein CJ
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7773-8. PubMed ID: 12808130
[TBL] [Abstract][Full Text] [Related]
52. Latent adenovirus infection in COPD.
Hayashi S
Chest; 2002 May; 121(5 Suppl):183S-187S. PubMed ID: 12010848
[TBL] [Abstract][Full Text] [Related]
53. E3-13.7 integral membrane proteins encoded by human adenoviruses alter epidermal growth factor receptor trafficking by interacting directly with receptors in early endosomes.
Crooks D; Kil SJ; McCaffery JM; Carlin C
Mol Biol Cell; 2000 Oct; 11(10):3559-72. PubMed ID: 11029055
[TBL] [Abstract][Full Text] [Related]
54. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.
Ben-Shushan E; Thompson JR; Gudas LJ; Bergman Y
Mol Cell Biol; 1998 Apr; 18(4):1866-78. PubMed ID: 9528758
[TBL] [Abstract][Full Text] [Related]
55. Adenovirus E1A products activate the Ig k-chain enhancer in fibroblasts. A possible involvement of the NF-kB binding site.
Shurman L; Sen R; Bergman Y
J Immunol; 1989 Dec; 143(11):3806-12. PubMed ID: 2531188
[TBL] [Abstract][Full Text] [Related]
56. Regulation of the Ig kappa-chain enhancer by the adenovirus E1A gene products. Repression in lymphoid cells, activation in fibroblasts.
Bergman Y; Shavit D
J Immunol; 1988 Mar; 140(6):2073-80. PubMed ID: 2964488
[TBL] [Abstract][Full Text] [Related]
57. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
Brockmann D; Schäfer D; Kirch HC; Esche H
Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
[TBL] [Abstract][Full Text] [Related]
58. Organization of the transcription factor binding sites in the kappa Ig intron enhancer. Effects of position, orientation, and spacing.
Schanke JT; Van Ness BG
J Immunol; 1994 Nov; 153(10):4565-72. PubMed ID: 7963528
[TBL] [Abstract][Full Text] [Related]
59. Differential nuclear expression of enhancer A DNA-binding proteins in human first trimester trophoblast cells.
Boucraut J; Hawley S; Robertson K; Bernard D; Loke YW; Le Bouteiller P
J Immunol; 1993 May; 150(9):3882-94. PubMed ID: 8473737
[TBL] [Abstract][Full Text] [Related]
60. E1a revisited: the case for multiple cooperative trans-activation domains.
Braithwaite AW; Nelson CC; Bellett AJ
New Biol; 1991 Jan; 3(1):18-26. PubMed ID: 1828178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
